Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
Reducing unnecessary emergency department visits and hospitalizations in the management of pediatric febrile neutropenia. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results